Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.64 |
| ▸ | MAPT | P10636 | 6/20 | 0.64 |
| ▸ | NPC1 | O15118 | 4/20 | 0.64 |
| ▸ | RAB9A | P51151 | 4/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | ALDH2 | P05091 | 11/20 | 0.62 |
| ▸ | MAOA | P21397 | 6/20 | 0.62 |
| ▸ | MAOB | P27338 | 6/20 | 0.62 |
| ▸ | TP53 | P04637 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | XDH | P47989 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15110348 | 0.88 | ALDH2 (0.63) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1724568 | 0.85 | MAPT (0.85) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL554685 | 0.85 | ALDH2 (0.67) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5497023 | 0.84 | ALDH2 (0.69) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL28648204 | 0.84 | MAPT (0.76) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16232228 | 0.84 | ALDH2 (0.73) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5489200 | 0.84 | ALDH2 (0.69) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL28643838 | 0.83 | MAPT (0.74) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19410274 | 0.83 | ALDH2 (0.68) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19410269 | 0.83 | ALDH2 (0.65) | ALDH1A1MAPTNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-20060173065-A1 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173065-A1 | Functionalized phenolic esters and amides and polymers therefrom | HAAO, HAO2, HCAR3 | ALDH1A1 132/4885MAPT 3480/4885NPC1 3222/4885 |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | HAO2, HCAR2, HAAO | ALDH1A1 137/4885MAPT 3453/4885NPC1 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.